One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Re-biopsy may guide novel immunosuppressive therapy in long-standing IgA nephropathy Free
doi : 10.1093/ndt/gfaf039
Volume 40, Issue 9, September 2025
Kidney expert consultation and the outcomes of in hospital acute kidney injury
doi : 10.1093/ndt/gfaf043
Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events Open Access
doi : 10.1093/ndt/gfaf053
Acute kidney injury, acute kidney disease and chronic kidney disease: challenges and research perspectives Free
doi : 10.1093/ndt/gfaf090
Early compensatory increase in single-kidney estimated GFR after unilateral nephrectomy is associated with a lower long-term risk of estimated GFR decline Open Access
doi : 10.1093/ndt/gfaf026
Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K Working Group of the ERA and ESPN Open Access
doi : 10.1093/ndt/gfaf035
Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance Free
doi : 10.1093/ndt/gfaf036
A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis Free
doi : 10.1093/ndt/gfaf037
COVID-19 infection and the progression of kidney disease in British Columbia, Canada Free
doi : 10.1093/ndt/gfaf040
Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial Open Access
doi : 10.1093/ndt/gfaf044
Personalized disease recurrence modeling using iPSC-derived podocytes in patients with idiopathic nephrotic syndrome Open Access
doi : 10.1093/ndt/gfaf045
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease Open Access
doi : 10.1093/ndt/gfaf046
Psoriasis associates with increased risk for kidney transplant rejection Free
doi : 10.1093/ndt/gfaf047
The long-term effect of tolvaptan treatment on kidney function and volume in patients with ADPKD Open Access
doi : 10.1093/ndt/gfaf048
Real world data on dual BLyS/APRIL inhibition with telitacicept for lupus nephritis Free
doi : 10.1093/ndt/gfaf049
ABCDE to identify and prevent chronic kidney disease: a call to action Open Access
doi : 10.1093/ndt/gfaf057
Recurrence of CKD-associated pruritus after discontinuation of difelikefalin Free
doi : 10.1093/ndt/gfaf081
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration Free
doi : 10.1093/ndt/gfaf085
Correction to: Urinary Dickkopf-3: a new biomarker for CKD progression and mortality Free
doi : 10.1093/ndt/gfaf129
Correction to: Biology of calcium homeostasis regulation in intestine and kidney Open Access
doi : 10.1093/ndt/gfaf131
